Abstract 7254: Mouse models for alleviating GvHD and assessing on-target off-tumor toxicity of bispecific T-cell engagers

毒性 医学 癌症研究 内科学
作者
Hongyan Sun,Bei Zhang,Yunlong Jiang,Jianming Xu,Xiangyu Gao,Jun Wang
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:85 (8_Supplement_1): 7254-7254
标识
DOI:10.1158/1538-7445.am2025-7254
摘要

Abstract Bispecific T cell engagers (TCEs), which simultaneously target CD3 on the surface of T cells and a tumor-associated antigen (TAA) located on cancer cells, have shown great promise in tumor treatment. However, multiple factors including targets, indications, dosage and immunogenicity influence the efficacy and safety of TCEs. Furthermore, the intricate mechanism of action may limit the translatability from preclinical study to clinical application. To improve the translation of early research findings into effective therapeutic strategies, we introduced two optimized mouse models for preclinical evaluation of TCEs. Due to poor cross-species reactivity of anti-CD3 and anti-TAA antibodies, mice that express wild type murine CD3 molecules are not suitable for the evaluation of TCEs. Severe immunodeficient animals engrafted with both human T cells and cancer cells represent an ideal model. However, graft-versus-host disease (GvHD) is often observed, which can make data interpretation challenging. To this end, the NCG-MHC-dKO mouse model was developed by knocking out both murine MHC class I and II molecules in the NCG background. Compared to conventional NCG mice, NCG-MHC-dKO mice alleviated the GvHD response and prolonged the life span of PBMC-engrafted animals, thereby extending the therapeutic window. We have verified the efficacy of talquetamab, a GPRC5D-directed T cell engager, in huPBMC-NCG-MHC-dKO mice inoculated with NCI-H929 cell line. Talquetamab could significantly inhibit tumor growth in NCG-MHC-dKO mice, with the animals maintaining stable body weight and healthy condition throughout the treatment period. These findings highlighted NCG-MHC-dKO mice as an ideal platform for evaluating the efficacy of TCEs. Although the huPBMC-NCG-MHC-dKO model is very powerful for the efficacy evaluation of TCEs, it cannot be used to evaluate on-target off-tumor toxicity due to the absence of human TAA in mouse tissues with compromised immune systems. To this end, the BALB/c-hCD3EDG mouse model was developed by inserting the entire gene regions including regulatory sequences of the human CD3E, CD3D, and CD3G genes into the mouse genome, while simultaneously deleting the endogenous mouse CD3e, CD3d, and CD3g genes. Replacing the murine CD3 molecules with human counterparts did not impact the immune system of BALB/c-hCD3EDG mice. In addition, we have developed multiple human TAA knock-in mouse models in the BALB/c-hCD3EDG background. The expression of TAAs in these mice resembled that in humans. Together, these models can be used not only to evaluate the efficacy, but also on-target off-tumor toxicity of TCEs. In conclusion, our mouse models provide valuable tools to increase the translatability of preclinical models to evaluate TCEs. Citation Format: Hongyan Sun, Bei Zhang, Yunlong Jiang, Jianming Xu, Xiang Gao, Jun Wang. Mouse models for alleviating GvHD and assessing on-target off-tumor toxicity of bispecific T-cell engagers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part 1 (Regular Abstracts); 2025 Apr 25-30; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2025;85(8_Suppl_1):Abstract nr 7254.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
JJW完成签到,获得积分10
刚刚
RXAFSH完成签到,获得积分10
1秒前
1秒前
1秒前
从容鞋子完成签到,获得积分10
1秒前
畅快的小懒虫完成签到,获得积分10
2秒前
hh285完成签到,获得积分10
2秒前
Danyang发布了新的文献求助10
3秒前
橙啦啦啦啦完成签到,获得积分10
3秒前
GuoH完成签到,获得积分10
3秒前
旺仔仔完成签到,获得积分10
3秒前
彩色的依琴完成签到,获得积分10
3秒前
徐滨完成签到,获得积分10
3秒前
现代的南风完成签到 ,获得积分10
3秒前
Vision完成签到,获得积分10
3秒前
zhao发布了新的文献求助10
4秒前
江東完成签到 ,获得积分10
4秒前
Gp1983发布了新的文献求助50
4秒前
plan完成签到 ,获得积分10
4秒前
森森完成签到,获得积分10
4秒前
2q完成签到 ,获得积分10
5秒前
Ricardo完成签到,获得积分10
5秒前
彩色的哈密瓜完成签到,获得积分10
5秒前
廿二完成签到 ,获得积分10
5秒前
牵墨完成签到,获得积分10
5秒前
老迟的新瑶完成签到 ,获得积分10
5秒前
浩然完成签到 ,获得积分10
5秒前
猫又完成签到 ,获得积分10
5秒前
Lee完成签到,获得积分10
6秒前
鲤鱼访梦完成签到 ,获得积分10
6秒前
池小鱼完成签到,获得积分10
6秒前
laoleigang完成签到,获得积分10
6秒前
承乐完成签到,获得积分10
6秒前
陈成完成签到,获得积分10
7秒前
Jing完成签到,获得积分10
7秒前
li完成签到 ,获得积分10
8秒前
研友_VZG7GZ的应助被隐形的紫菜采纳,获得20
8秒前
fiona完成签到,获得积分0
8秒前
CHME完成签到 ,获得积分10
10秒前
Jasper的应助被漂亮的千万采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039